369 related articles for article (PubMed ID: 15994952)
1. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
Yang S; Lim M; Pham LK; Kendall SE; Reddi AH; Altieri DC; Roy-Burman P
Cancer Res; 2006 Apr; 66(8):4285-90. PubMed ID: 16618753
[TBL] [Abstract][Full Text] [Related]
3. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2008 Jan; 68(1):198-205. PubMed ID: 18172312
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein signaling in prostate cancer cell lines.
Brubaker KD; Corey E; Brown LG; Vessella RL
J Cell Biochem; 2004 Jan; 91(1):151-60. PubMed ID: 14689587
[TBL] [Abstract][Full Text] [Related]
6. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways.
Piscione TD; Phan T; Rosenblum ND
Am J Physiol Renal Physiol; 2001 Jan; 280(1):F19-33. PubMed ID: 11133511
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
8. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.
Ide H; Yoshida T; Matsumoto N; Aoki K; Osada Y; Sugimura T; Terada M
Cancer Res; 1997 Nov; 57(22):5022-7. PubMed ID: 9371496
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Hardwick JC; Van Den Brink GR; Bleuming SA; Ballester I; Van Den Brande JM; Keller JJ; Offerhaus GJ; Van Deventer SJ; Peppelenbosch MP
Gastroenterology; 2004 Jan; 126(1):111-21. PubMed ID: 14699493
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
11. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
12. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
14. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
16. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
17. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway.
Ye L; Kynaston H; Jiang WG
J Urol; 2009 Jun; 181(6):2749-59. PubMed ID: 19375725
[TBL] [Abstract][Full Text] [Related]
19. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling.
Rios I; Alvarez-Rodríguez R; Martí E; Pons S
Development; 2004 Jul; 131(13):3159-68. PubMed ID: 15197161
[TBL] [Abstract][Full Text] [Related]
20. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
